The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.
 
Maristella Saponara
No Relationships to Disclose
 
Bruno Vincenzi
Research Funding - PharmaMar (Inst)
 
Giuseppe Badalamenti
No Relationships to Disclose
 
Carlo Morosi
No Relationships to Disclose
 
Silvana Pilotti
No Relationships to Disclose
 
Gianpaolo Dagrada
No Relationships to Disclose
 
Salvatore Provenzano
No Relationships to Disclose
 
Michela Libertini
Research Funding - PharmaMar (Inst)
 
Rossella Bertulli
Research Funding - PharmaMar (Inst)
 
Vittoria Colia
Research Funding - PharmaMar (Inst)
 
Angelo Paolo Dei Tos
Honoraria - PharmaMar
Consulting or Advisory Role - PharmaMar
 
Paolo Giovanni Casali
Honoraria - Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Amgen/Dompé; ARIAD/Merck; Bayer; Blueprint Medicines; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar
Research Funding - Amgen/Dompé (Inst); Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); MolMed (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Novartis; PharmaMar
 
Silvia Stacchiotti
Honoraria - PharmaMar
Consulting or Advisory Role - PharmaMar
Research Funding - PharmaMar (Inst)